Biomarker enterprise to attack DKD
Project factsheets
The Innovative Health Initiative builds on the successes of the Innovative Medicines Initiative (IMI), which launched over 180 projects. Many IMI projects are still ongoing and are monitored by the IHI Programme Office. This section features the factsheets of all IMI projects. Once IHI projects are up and running, we will also promote them here.
Displaying 17 projects/programmes
Cardiomyopathy in type 2 diabetes mellitus
Diabetes research on patient stratification
European Bank for induced pluripotent Stem Cells
European Medical Information Framework
EU patient-centric clinical trial platform
H2O Health outcomes observatory
Hypoglycaemia - REdefining SOLutions for better liVEs
Investigating mechanisms and models predictive of accessibility of therapeutics (IM2PACT) into the brain
Improving beta-cell function and identification of diagnostic biomarkers For treatment monitoring in diabetes
Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes.
Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA
Liver Investigation: Testing Marker Utility in Steatohepatitis
Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification
Stratification of obese phenotypes to optimize future obesity therapy
Stem cells for biological assays of novel drugs and predictive toxicology
Surrogate markers for micro- and macro-vascular hard endpoints for innovative diabetes tools
